Clendening John S 4
4 · BLUCORA, INC. · Filed Jul 18, 2019
Insider Transaction Report
Form 4
BLUCORA, INC.BCOR
Clendening John S
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2019-07-16$4.98/sh+37,500$186,750→ 721,217 total - Sale
Common Stock
2019-07-16$29.01/sh−54,250$1,573,793→ 666,967 total - Exercise/Conversion
Common Stock
2019-07-17$4.98/sh+10,000$49,800→ 676,967 total - Sale
Common Stock
2019-07-17$29.23/sh−10,000$292,300→ 666,967 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-07-16−37,500→ 59,499 totalExercise: $4.98Exp: 2023-04-04→ Common Stock (37,500 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2019-07-17−10,000→ 49,499 totalExercise: $4.98Exp: 2023-04-04→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $28.74 to $29.18. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares purchased at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $28.98 to $29.40. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price.
- [F4]15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017, and approximately 16.67% vested at the end of each six-month period thereafter, such that the option was be fully vested on April 4, 2019.